Ryohei Inanaga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ryohei Inanaga has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Noriaki Kurita
Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima City, Japan
13 shared publications - Tatsunori Toida
Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan
9 shared publications - Tomo Suzuki
Department of Nephrology Kameda Medical Center Chiba Japan
8 shared publications Atsuro Kawaji
Department of Nephrology, Kameda Medical Center, Chiba, Japan
7 shared publications- Mamiko Ukai
Tessyoukai Kameda Family Clinic Tateyama, Chiba, Japan
7 shared publications - Masatoshi Matsunami
Department of Nephrology Kameda Medical Center Chiba Japan
7 shared publications
Latest Publications
- 1 June 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (5) , 1031-1041
Determinants and implications of reluctance to disclose personal values in the shared decision-making process for kidney replacement therapy
Background: In selecting kidney replacement therapy (KRT), shared decision-making assumes patients are willing to disclose personal values and preferences. However, the prevalence, reasons, and implications of patients' reluctance to share such information remain unclear. This study examined these aspects using a convergent mixed-methods design. Methods: A nationwide cross-sectional survey was conducted among Japanese adults with stage 5 chronic kidney disease who had selected a KRT modality at one of 49 facilities. Factors associated with reluctance to share were analyzed using ordinal logistic regression. The association between reluctance and the extent of shared decision-making, assessed by the CollaboRATE scale, was examined using a general linear model. Qualitative content analysis of free-text responses identified reasons and themes underlying reluctance. Results: Among 474 patients analyzed, 111 (24.2%) reported being very or somewhat reluctant to share. Compared with those not at all reluctant, patients who were minimally and very/somewhat reluctant had lower CollaboRATE scores (−5.12 and −11.39 points, respectively). Greater trust in the primary nephrologist was protective against reluctance, whereas depressive symptoms promoted it. Qualitative analyses identified five themes: Privacy Sensitivity Diversity, Decision-Making Attitudes and Preferences, and Personality and Psychological Adaptation in Decision-Making shaped the direction of reluctance, while Priorities on Health Over Privacy and Trust in Providers helped overcome it. Conclusions: A substantial proportion of patients expressed reluctance to share personal values. Fostering trust, addressing emotional and privacy-related concerns, and exploring the diversity in patients' decision-making preferences and personality traits may promote truly patient-centered decision-making.
- 1 June 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (5) , 1031-1041
Determinants and implications of reluctance to disclose personal values in the shared decision-making process for kidney replacement therapy
Background: In selecting kidney replacement therapy (KRT), shared decision-making assumes patients are willing to disclose personal values and preferences. However, the prevalence, reasons, and implications of patients' reluctance to share such information remain unclear. This study examined these aspects using a convergent mixed-methods design. Methods: A nationwide cross-sectional survey was conducted among Japanese adults with stage 5 chronic kidney disease who had selected a KRT modality at one of 49 facilities. Factors associated with reluctance to share were analyzed using ordinal logistic regression. The association between reluctance and the extent of shared decision-making, assessed by the CollaboRATE scale, was examined using a general linear model. Qualitative content analysis of free-text responses identified reasons and themes underlying reluctance. Results: Among 474 patients analyzed, 111 (24.2%) reported being very or somewhat reluctant to share. Compared with those not at all reluctant, patients who were minimally and very/somewhat reluctant had lower CollaboRATE scores (−5.12 and −11.39 points, respectively). Greater trust in the primary nephrologist was protective against reluctance, whereas depressive symptoms promoted it. Qualitative analyses identified five themes: Privacy Sensitivity Diversity, Decision-Making Attitudes and Preferences, and Personality and Psychological Adaptation in Decision-Making shaped the direction of reluctance, while Priorities on Health Over Privacy and Trust in Providers helped overcome it. Conclusions: A substantial proportion of patients expressed reluctance to share personal values. Fostering trust, addressing emotional and privacy-related concerns, and exploring the diversity in patients' decision-making preferences and personality traits may promote truly patient-centered decision-making.
- Open Access
- 26 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1825-1834
Association of Formal and Informal Advance Care Planning with Multidimensional Health Literacy in Patients Undergoing Hemodialysis
Key Points: Higher critical health literacy was associated with informal advance care planning, while higher total health literacy was associated with both informal and formal advance care planning in patients receiving hemodialysis. Patients unsure about treatment preferences had lower total health literacy, and lack of opportunity was the most common barrier to advance care planning engagement. Enhancing health literacy and providing structured opportunities for advance care planning may support patient-centered decision making in dialysis care. Background: Although qualitative studies suggest that health literacy (HL) may influence engagement in advance care planning (ACP) among patients undergoing dialysis, this association has not been quantitatively examined. We investigated whether multidimensional HL is associated with participation in informal and formal ACP and end-of-life care preferences. Methods: This multicenter cross-sectional study included adult patients receiving hemodialysis from six facilities in Japan. Participation in informal and formal ACP was assessed using a questionnaire, and HL was measured with the Functional, Communicative, and Critical Health Literacy scale. Associations between HL and ACP participation were analyzed using logistic regression models. We also examined patients' end-of-life care preferences in the event of serious future health deterioration. Results: Among 651 eligible patients, 466 were included in the analysis (median age, 71 years; 35% women). Informal ACP participation was reported by 52% of patients, whereas formal ACP participation was 5%. Higher critical HL was independently associated with informal ACP participation (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.25 to 3.00), while higher total HL was associated with formal ACP participation (OR, 4.18; 95% CI, 1.63 to 10.77). Women and diabetes were associated with informal ACP and female sex with formal ACP. Patients who reported being unsure about future treatment preferences had lower total HL and were younger (total HL: OR, 0.63; 95% CI, 0.42 to 0.95; age: OR, 0.79; 95% CI, 0.66 to 0.95). The most common reason for not engaging in ACP discussions was a lack of opportunity to discuss ACP (71/151). Conclusions: Critical HL was associated with informal ACP participation, whereas total HL was associated with formal ACP among patients undergoing hemodialysis. In addition, the most frequently reported barrier to ACP engagement was a lack of opportunity for discussion, highlighting the need to both enhance HL and establish structured opportunities for ACP to support patient-centered decision making.
- 26 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1825-1834
Open AccessAssociation of Formal and Informal Advance Care Planning with Multidimensional Health Literacy in Patients Undergoing Hemodialysis
Key Points: Higher critical health literacy was associated with informal advance care planning, while higher total health literacy was associated with both informal and formal advance care planning in patients receiving hemodialysis. Patients unsure about treatment preferences had lower total health literacy, and lack of opportunity was the most common barrier to advance care planning engagement. Enhancing health literacy and providing structured opportunities for advance care planning may support patient-centered decision making in dialysis care. Background: Although qualitative studies suggest that health literacy (HL) may influence engagement in advance care planning (ACP) among patients undergoing dialysis, this association has not been quantitatively examined. We investigated whether multidimensional HL is associated with participation in informal and formal ACP and end-of-life care preferences. Methods: This multicenter cross-sectional study included adult patients receiving hemodialysis from six facilities in Japan. Participation in informal and formal ACP was assessed using a questionnaire, and HL was measured with the Functional, Communicative, and Critical Health Literacy scale. Associations between HL and ACP participation were analyzed using logistic regression models. We also examined patients' end-of-life care preferences in the event of serious future health deterioration. Results: Among 651 eligible patients, 466 were included in the analysis (median age, 71 years; 35% women). Informal ACP participation was reported by 52% of patients, whereas formal ACP participation was 5%. Higher critical HL was independently associated with informal ACP participation (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.25 to 3.00), while higher total HL was associated with formal ACP participation (OR, 4.18; 95% CI, 1.63 to 10.77). Women and diabetes were associated with informal ACP and female sex with formal ACP. Patients who reported being unsure about future treatment preferences had lower total HL and were younger (total HL: OR, 0.63; 95% CI, 0.42 to 0.95; age: OR, 0.79; 95% CI, 0.66 to 0.95). The most common reason for not engaging in ACP discussions was a lack of opportunity to discuss ACP (71/151). Conclusions: Critical HL was associated with informal ACP participation, whereas total HL was associated with formal ACP among patients undergoing hemodialysis. In addition, the most frequently reported barrier to ACP engagement was a lack of opportunity for discussion, highlighting the need to both enhance HL and establish structured opportunities for ACP to support patient-centered decision making.
- 1 March 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (2) , 353-363
Prevalence of financial toxicity and its association with medication adherence among patients undergoing haemodialysis under comprehensive public support in Japan
Background: Beyond affordability, financial strain can induce psychological stress and a sense of financial distress, collectively termed “financial toxicity”. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of financial toxicity and its effects on medication adherence. This study aimed to assess the prevalence of financial toxicity and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods: This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. Financial toxicity and self-reported medication adherence were assessed using the Comprehensive Score for Financial Toxicity (COST) and the 12-item Adherence Starts with Knowledge (ASK-12) scale, respectively. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. A mediation analysis was conducted to explore potential pathways underlying this association. Results: In total, 455 participants were included. The mean COST score was 22.0, and 68.5% of the participants experienced at least mild financial toxicity. Financial toxicity severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower financial toxicity (higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = −.17). The mediation analysis suggested that emotional impact represents one pathway linking financial toxicity to adherence difficulties. Conclusions: Despite generous public coverage, financial toxicity is common among Japanese patients undergoing haemodialysis and is associated with subjective difficulties in medication adherence.
- 1 March 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (2) , 353-363
Prevalence of financial toxicity and its association with medication adherence among patients undergoing haemodialysis under comprehensive public support in Japan
Background: Beyond affordability, financial strain can induce psychological stress and a sense of financial distress, collectively termed “financial toxicity”. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of financial toxicity and its effects on medication adherence. This study aimed to assess the prevalence of financial toxicity and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods: This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. Financial toxicity and self-reported medication adherence were assessed using the Comprehensive Score for Financial Toxicity (COST) and the 12-item Adherence Starts with Knowledge (ASK-12) scale, respectively. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. A mediation analysis was conducted to explore potential pathways underlying this association. Results: In total, 455 participants were included. The mean COST score was 22.0, and 68.5% of the participants experienced at least mild financial toxicity. Financial toxicity severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower financial toxicity (higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = −.17). The mediation analysis suggested that emotional impact represents one pathway linking financial toxicity to adherence difficulties. Conclusions: Despite generous public coverage, financial toxicity is common among Japanese patients undergoing haemodialysis and is associated with subjective difficulties in medication adherence.
- Open Access
- 21 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e90010
Correction: Smartphone App–Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial
- 21 January 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e90010
Open AccessCorrection: Smartphone App–Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial
- Open Access
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e78612
Smartphone App–Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial
Background: Increased appetite and weight gain are common adverse effects of glucocorticoid therapy in patients with systemic lupus erythematosus (SLE). Concerns about appearance-related changes due to weight gain can reduce medication adherence. Moreover, the complex interplay among glucocorticoids, mood changes, sleep disturbances, and appetite can influence eating behaviors. Daily data collection using ecological momentary assessment and analysis of interrelations may help clarify these dynamics. Furthermore, real-time feedback based on daily eating behavior may help patients regulate appetite and eating patterns. Accordingly, we developed Mogu!☆Log, a smartphone-based app that enables daily self-reporting of eating behaviors, appetite, and mood and provides graphical feedback on meal frequency and perceived control over eating. Objective: This paper presents a protocol for a pilot randomized controlled trial designed to evaluate the effects of real-time feedback on eating behaviors using the Mogu!☆Log app among patients with newly diagnosed SLE who had started glucocorticoid therapy. Methods: This multicenter study recruited Japanese patients with newly diagnosed SLE who had started glucocorticoid therapy across 15 hospitals with rheumatology services. Participants were randomly assigned in a 1:1 ratio to two groups: (1) the immediate feedback group, which receives graphical feedback on meal frequency and perceived control over eating starting from day 1, and (2) the delayed feedback group, which uses the same app without feedback for the first 14 days and begins receiving identical feedback from day 15. Participants enter data daily from day 1 to day 21 after randomization. The primary outcome is the mean number of meals on day 14 after glucocorticoid initiation. Secondary outcomes include the loss-of-control-over-eating score and a 5-item visual analog scale–based appetite score, both recorded on day 14. Between-group mean differences will be analyzed using 2-tailed t tests. The target sample size is 60. In an embedded observational “study within a trial,” linear mixed models will examine whether glucocorticoid dose influences appetite scores through mood and sleep changes. Results: We hypothesized that participants receiving immediate feedback will have fewer meals on day 14, reduced loss of control over eating, and better appetite scores. The study received funding in April 2019, April 2022, and April 2024. Recruitment began in October 2024, and 17 participants had been enrolled as of May 2025. Data collection is expected to be completed by March 2027; data analysis has yet to begin. Results will be submitted for publication and reported to the University Hospital Medical Information Network (UMIN) registry in the summer of 2027. Conclusions: This pilot trial will provide foundational data on the feasibility and efficacy of smartphone-based real-time feedback in managing glucocorticoid-induced appetite increase in patients with SLE. These findings may contribute to the growing body of literature on app-based interventions for medication-related adverse effects.
- 15 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e78612
Open AccessSmartphone App–Based Eating Behavior Monitoring and Feedback Intervention for Glucocorticoid-Induced Appetite Increase in Patients With Systemic Lupus Erythematosus: Protocol for a Pilot Randomized Controlled Trial
Background: Increased appetite and weight gain are common adverse effects of glucocorticoid therapy in patients with systemic lupus erythematosus (SLE). Concerns about appearance-related changes due to weight gain can reduce medication adherence. Moreover, the complex interplay among glucocorticoids, mood changes, sleep disturbances, and appetite can influence eating behaviors. Daily data collection using ecological momentary assessment and analysis of interrelations may help clarify these dynamics. Furthermore, real-time feedback based on daily eating behavior may help patients regulate appetite and eating patterns. Accordingly, we developed Mogu!☆Log, a smartphone-based app that enables daily self-reporting of eating behaviors, appetite, and mood and provides graphical feedback on meal frequency and perceived control over eating. Objective: This paper presents a protocol for a pilot randomized controlled trial designed to evaluate the effects of real-time feedback on eating behaviors using the Mogu!☆Log app among patients with newly diagnosed SLE who had started glucocorticoid therapy. Methods: This multicenter study recruited Japanese patients with newly diagnosed SLE who had started glucocorticoid therapy across 15 hospitals with rheumatology services. Participants were randomly assigned in a 1:1 ratio to two groups: (1) the immediate feedback group, which receives graphical feedback on meal frequency and perceived control over eating starting from day 1, and (2) the delayed feedback group, which uses the same app without feedback for the first 14 days and begins receiving identical feedback from day 15. Participants enter data daily from day 1 to day 21 after randomization. The primary outcome is the mean number of meals on day 14 after glucocorticoid initiation. Secondary outcomes include the loss-of-control-over-eating score and a 5-item visual analog scale–based appetite score, both recorded on day 14. Between-group mean differences will be analyzed using 2-tailed t tests. The target sample size is 60. In an embedded observational “study within a trial,” linear mixed models will examine whether glucocorticoid dose influences appetite scores through mood and sleep changes. Results: We hypothesized that participants receiving immediate feedback will have fewer meals on day 14, reduced loss of control over eating, and better appetite scores. The study received funding in April 2019, April 2022, and April 2024. Recruitment began in October 2024, and 17 participants had been enrolled as of May 2025. Data collection is expected to be completed by March 2027; data analysis has yet to begin. Results will be submitted for publication and reported to the University Hospital Medical Information Network (UMIN) registry in the summer of 2027. Conclusions: This pilot trial will provide foundational data on the feasibility and efficacy of smartphone-based real-time feedback in managing glucocorticoid-induced appetite increase in patients with SLE. These findings may contribute to the growing body of literature on app-based interventions for medication-related adverse effects.
- Open Access
Prevalence of Financial Toxicity and Its Association with Medication Adherence Among Patients Undergoing Haemodialysis Under Comprehensive Public Support in Japan
Background and hypothesis Financial toxicity (FT) refers not only to the difficulty in affording medical care but also to the psychological distress and perceived financial burden it imposes. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of FT and its effects on medication adherence. This study aimed to assess the prevalence of FT and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. FT was assessed using the Comprehensive Score for Financial Toxicity (COST), and medication adherence was assessed using the 12-item Adherence Starts with Knowledge (ASK-12) scale. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. Results In total, 455 participants were included in the analysis. The mean COST score was 22.0, and 68% of the participants experienced at least mild FT. FT severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower FT (i.e., higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = –0.19). This association was particularly evident in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains (per 1-point higher: β = –0.06 and β = –0.08, respectively). Conclusions Despite generous public coverage, FT is common among Japanese patients undergoing haemodialysis and is associated with difficulties in medication adherence. The awareness of hidden financial distress and its integration into shared decision-making regarding prescriptions may help improve treatment adherence and patient outcomes. What was known Among patients undergoing dialysis, medication adherence rates are generally < 70%. ‘Financial toxicity’ is associated with poor medication adherence in oncology. However, among patients undergoing dialysis receiving publicly funded care, the prevalence of financial toxicity and its effects on medication adherence remain unclear. This study adds Despite Japan’s comprehensive public insurance system, approximately 70% of patients undergoing dialysis experience at least mild financial toxicity levels, comparable to those observed in Japanese patients with cancer. Lower financial toxicity was associated with better medication adherence, particularly in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains. Potential impact Financial hardship can cause stress. Healthcare providers should build trust with their patients and foster open discussions on financial and social challenges. Practising shared decision-making is essential for prescribing medications that consider patients’ financial burden. Providing work-friendly dialysis schedules may support patients’ long-term financial independence.
Open AccessPrevalence of Financial Toxicity and Its Association with Medication Adherence Among Patients Undergoing Haemodialysis Under Comprehensive Public Support in Japan
Background and hypothesis Financial toxicity (FT) refers not only to the difficulty in affording medical care but also to the psychological distress and perceived financial burden it imposes. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of FT and its effects on medication adherence. This study aimed to assess the prevalence of FT and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. FT was assessed using the Comprehensive Score for Financial Toxicity (COST), and medication adherence was assessed using the 12-item Adherence Starts with Knowledge (ASK-12) scale. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. Results In total, 455 participants were included in the analysis. The mean COST score was 22.0, and 68% of the participants experienced at least mild FT. FT severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower FT (i.e., higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = –0.19). This association was particularly evident in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains (per 1-point higher: β = –0.06 and β = –0.08, respectively). Conclusions Despite generous public coverage, FT is common among Japanese patients undergoing haemodialysis and is associated with difficulties in medication adherence. The awareness of hidden financial distress and its integration into shared decision-making regarding prescriptions may help improve treatment adherence and patient outcomes. What was known Among patients undergoing dialysis, medication adherence rates are generally < 70%. ‘Financial toxicity’ is associated with poor medication adherence in oncology. However, among patients undergoing dialysis receiving publicly funded care, the prevalence of financial toxicity and its effects on medication adherence remain unclear. This study adds Despite Japan’s comprehensive public insurance system, approximately 70% of patients undergoing dialysis experience at least mild financial toxicity levels, comparable to those observed in Japanese patients with cancer. Lower financial toxicity was associated with better medication adherence, particularly in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains. Potential impact Financial hardship can cause stress. Healthcare providers should build trust with their patients and foster open discussions on financial and social challenges. Practising shared decision-making is essential for prescribing medications that consider patients’ financial burden. Providing work-friendly dialysis schedules may support patients’ long-term financial independence.
- Open Access
Impact of Dialysis Duration and Frailty on Frailty Progression: A Japanese Nationwide Cohort Study
Importance Frailty is common among dialysis patients and significantly affects the quality of life for both patients and their caregivers. However, limited evidence exists on the long- term changes in physical function in this population. Objective To examine 8-year trajectories of physical function and assess associations with baseline dialysis duration and physical function status among Japanese dialysis patients. Design Nationwide, cohort study. Setting Japan; data obtained from a registry. Participants 223,501 Japanese adults receiving hemodialysis enrolled in the 2010 Japanese Society for Dialysis Therapy Renal Data Registry. Exposures Baseline dialysis duration (Main Outcomes and Measures Physical function at 8 years was similarly classified as non- frail, frail, bedridden, or deceased. Multinomial logistic regression was used to estimate adjusted odds ratios, average marginal effects, and predicted probabilities based on baseline exposures. Results Among patients with complete baseline and 8-year follow-up data, 59.9% died, 8.8% became frail, 2.4% were bedridden, and 28.9% remained non-frail. Longer dialysis duration and baseline frailty or bedridden status were associated with increased odds of subsequent frailty, bedridden status, and mortality. Compared with patients with Conclusions and Relevance In this nationwide 8-year study, majority of the hemodialysis patients experienced either death or functional decline. Longer dialysis duration and baseline frailty were associated with adverse outcomes, although absolute increases in frailty were modest. These findings highlight the need for early, values-based shared decision-making in the management of dialysis patients.
Open AccessImpact of Dialysis Duration and Frailty on Frailty Progression: A Japanese Nationwide Cohort Study
Importance Frailty is common among dialysis patients and significantly affects the quality of life for both patients and their caregivers. However, limited evidence exists on the long- term changes in physical function in this population. Objective To examine 8-year trajectories of physical function and assess associations with baseline dialysis duration and physical function status among Japanese dialysis patients. Design Nationwide, cohort study. Setting Japan; data obtained from a registry. Participants 223,501 Japanese adults receiving hemodialysis enrolled in the 2010 Japanese Society for Dialysis Therapy Renal Data Registry. Exposures Baseline dialysis duration (Main Outcomes and Measures Physical function at 8 years was similarly classified as non- frail, frail, bedridden, or deceased. Multinomial logistic regression was used to estimate adjusted odds ratios, average marginal effects, and predicted probabilities based on baseline exposures. Results Among patients with complete baseline and 8-year follow-up data, 59.9% died, 8.8% became frail, 2.4% were bedridden, and 28.9% remained non-frail. Longer dialysis duration and baseline frailty or bedridden status were associated with increased odds of subsequent frailty, bedridden status, and mortality. Compared with patients with Conclusions and Relevance In this nationwide 8-year study, majority of the hemodialysis patients experienced either death or functional decline. Longer dialysis duration and baseline frailty were associated with adverse outcomes, although absolute increases in frailty were modest. These findings highlight the need for early, values-based shared decision-making in the management of dialysis patients.
- Open Access
Shared Decision-Making in Renal Replacement Therapy Selection: Patient Perceptions, Preferences, and Influencing Factors in a Nationwide Cross-Sectional Study in Japan
Background: Shared decision-making (SDM) is a key process in selecting renal replacement therapy (RRT). This study analyzed SDM perceptions, preferences, and patient- and facility-level factors influencing SDM among Japanese patients with chronic kidney disease (CKD) who selected RRT. Methods: We analyzed 475 adult patients with CKD from 49 medical facilities. SDM awareness and recognition, preferences for SDM timing and frequency, discussion content, and desired professional involvement were assessed. Patient- and facility-level factors associated with SDM perceptions were evaluated using Poisson regression with cluster-robust variance estimation. Results: The mean age of participants was 67.4 years. Overall, 71%, 24.4%, and 4.4% chose hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. While 81.2% perceived that SDM was performed during RRT selection, only 4.7% were explicitly aware of the concept. Patients prioritized discussions about effects on daily life, financial burden, and family-related concerns. Most preferred SDM initiation when RRT was imminent, conducted over multiple sessions. Many patients valued the involvement of medical social workers and their usual non-nephrologist physicians in addition to nephrologists. Multiple outpatient visits for RRT selection, involving nurse participation and extended consultation times, were significantly associated with SDM perceptions (prevalence ratio: 1.59, 95% confidence interval: 1.05–2.42). Conclusions: Many Japanese patients with CKD perceived SDM during RRT selection; however, they had limited awareness of the concept. The findings underscore the importance of establishing a system that facilitates repeated SDM discussions at critical moments for patients. These discussions should emphasize the impact of RRT on patients’ lives and involve a multidisciplinary team.
Open AccessShared Decision-Making in Renal Replacement Therapy Selection: Patient Perceptions, Preferences, and Influencing Factors in a Nationwide Cross-Sectional Study in Japan
Background: Shared decision-making (SDM) is a key process in selecting renal replacement therapy (RRT). This study analyzed SDM perceptions, preferences, and patient- and facility-level factors influencing SDM among Japanese patients with chronic kidney disease (CKD) who selected RRT. Methods: We analyzed 475 adult patients with CKD from 49 medical facilities. SDM awareness and recognition, preferences for SDM timing and frequency, discussion content, and desired professional involvement were assessed. Patient- and facility-level factors associated with SDM perceptions were evaluated using Poisson regression with cluster-robust variance estimation. Results: The mean age of participants was 67.4 years. Overall, 71%, 24.4%, and 4.4% chose hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. While 81.2% perceived that SDM was performed during RRT selection, only 4.7% were explicitly aware of the concept. Patients prioritized discussions about effects on daily life, financial burden, and family-related concerns. Most preferred SDM initiation when RRT was imminent, conducted over multiple sessions. Many patients valued the involvement of medical social workers and their usual non-nephrologist physicians in addition to nephrologists. Multiple outpatient visits for RRT selection, involving nurse participation and extended consultation times, were significantly associated with SDM perceptions (prevalence ratio: 1.59, 95% confidence interval: 1.05–2.42). Conclusions: Many Japanese patients with CKD perceived SDM during RRT selection; however, they had limited awareness of the concept. The findings underscore the importance of establishing a system that facilitates repeated SDM discussions at critical moments for patients. These discussions should emphasize the impact of RRT on patients’ lives and involve a multidisciplinary team.
- Open Access
Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: A cross-sectional study
Rationale & Objective Person-centered care (PCC) and trust in physicians influence medication adherence (MA) among patients undergoing dialysis. However, the mechanisms linking PCC to MA, particularly the mediating effect of trust in physicians, remain unclear. This study aimed to investigate the interrelationships between PCC, trust in physicians, and MA. Study Design Multicenter cross-sectional study. Setting & Participants Japanese adults receiving outpatient hemodialysis at six dialysis centers. Exposures PCC was assessed using the 13-item Japanese Primary Care Assessment Tool-Short Form, which included longitudinality and coordination of care. Trust in physicians was measured using the five-item Wake Forest Physician Trust Scale. Outcome MA was measured using the 12-item Adherence Starts Knowledge (ASK-12) scale. Analytical Approach General linear models were used to examine the relationships between PCC, trust in physicians, and MA. Mediation analysis determined the extent to which trust in physicians mediated the PCC-MA relationship. Results In total, 483 patients were analyzed. High-quality PCC was associated with lower barriers to MA in a dose-response manner across JPCAT-SF quartiles compared to no usual source of care (Q1: −3.90 (95% CI: −5.95 to −1.75); Q2: −4.78 (95% confidence interval [CI]: −7.02 to −2.69); Q3: −4.69 (95% CI: −6.96 to −2.58); Q4: −4.95 (95% CI: −7.21 to −2.62). Trust in physicians partially mediated this relationship in a dose-response pattern, with the proportion of the indirect effect increasing from 16.1% (95% CI: 4.5 to 33.8%) in Q2 to 33.3% (95% CI: 17.4 to 65.5%) in Q4. Similar findings were observed for PCC subdomains. Limitation Possible reverse causation. Conclusions High-quality PCC was associated with MA, with trust in physicians playing a key mediating role. Strategies to enhance MA in patients undergoing hemodialysis should incorporate multidimensional PCC approaches, focusing on building trust and strengthening continuity and coordination of care.
Open AccessTrust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: A cross-sectional study
Rationale & Objective Person-centered care (PCC) and trust in physicians influence medication adherence (MA) among patients undergoing dialysis. However, the mechanisms linking PCC to MA, particularly the mediating effect of trust in physicians, remain unclear. This study aimed to investigate the interrelationships between PCC, trust in physicians, and MA. Study Design Multicenter cross-sectional study. Setting & Participants Japanese adults receiving outpatient hemodialysis at six dialysis centers. Exposures PCC was assessed using the 13-item Japanese Primary Care Assessment Tool-Short Form, which included longitudinality and coordination of care. Trust in physicians was measured using the five-item Wake Forest Physician Trust Scale. Outcome MA was measured using the 12-item Adherence Starts Knowledge (ASK-12) scale. Analytical Approach General linear models were used to examine the relationships between PCC, trust in physicians, and MA. Mediation analysis determined the extent to which trust in physicians mediated the PCC-MA relationship. Results In total, 483 patients were analyzed. High-quality PCC was associated with lower barriers to MA in a dose-response manner across JPCAT-SF quartiles compared to no usual source of care (Q1: −3.90 (95% CI: −5.95 to −1.75); Q2: −4.78 (95% confidence interval [CI]: −7.02 to −2.69); Q3: −4.69 (95% CI: −6.96 to −2.58); Q4: −4.95 (95% CI: −7.21 to −2.62). Trust in physicians partially mediated this relationship in a dose-response pattern, with the proportion of the indirect effect increasing from 16.1% (95% CI: 4.5 to 33.8%) in Q2 to 33.3% (95% CI: 17.4 to 65.5%) in Q4. Similar findings were observed for PCC subdomains. Limitation Possible reverse causation. Conclusions High-quality PCC was associated with MA, with trust in physicians playing a key mediating role. Strategies to enhance MA in patients undergoing hemodialysis should incorporate multidimensional PCC approaches, focusing on building trust and strengthening continuity and coordination of care.
- Open Access
- 14 August 2024
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (12) , 873
Urine calcium oxalate monohydrate crystals in ethylene glycol intoxication
Naohiro Muraki, MD, Keiichiro Hori, MD, Ryohei Inanaga, MD, Naoto Hamano, MD, Katsuomi Matsui, MD, PhD, Michiya Shinozaki, MD, PhD; Urine calcium oxalate m
- 14 August 2024
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 117 (12) , 873
Open AccessUrine calcium oxalate monohydrate crystals in ethylene glycol intoxication
Naohiro Muraki, MD, Keiichiro Hori, MD, Ryohei Inanaga, MD, Naoto Hamano, MD, Katsuomi Matsui, MD, PhD, Michiya Shinozaki, MD, PhD; Urine calcium oxalate m